Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue

AUSTIN, Texas, July 8, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced 2nd quarter 2020 revenues of between $109 and $110 million, up more than 30% over the 2nd quarter of 2019. Highlights include: Molecular Diagnostics revenue of approximately $65 million, up over 100% vs. Q2 2019 Sample-to-answer MDx revenue of approximately $30 million, up... Read more

Thermo Fisher Scientific Provides Update to Second Quarter Outlook and Will Hold its Q2 Earnings Conference Call on Wednesday, July 22, 2020

Thermo Fisher Scientific Provides Update to Second Quarter Outlook and Will Hold its Q2 Earnings Conference Call on Wednesday, July 22, 2020 WALTHAM, Mass., July 6, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that, based on currently available information, it estimates that both reported and... Read more

Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners

AUSTIN, Texas, July 1, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life Science Research Partners, achieving a major milestone in the company’s strategy to extend its xMAP Technology with new functionality to facilitate new applications. Initially intended... Read more

Roche announces new data at the ISTH 2020 Congress, demonstrating ongoing commitment to advancing care for people with haemophilia A

Spark Therapeutics will present data from the initial dose cohorts of its phase I/II SPK-8011 gene therapy study, showing stable and durable factor VIII expression, substantial improvement in annualised bleed rate for more than two years, and an acceptable safety profile after more than two years of follow-up1 Roche will present second interim analysis results... Read more

Xylem Closes $1 Billion Inaugural Green Bond

Proceeds will fund eligible projects under Green Finance Framework Further enhances strong liquidity position, adds flexibility at attractive rates Builds on sustainability track record and recognized sustainability leadership in sector RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 29, 2020– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues,... Read more

Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithm

uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivity Roche advances personalised healthcare with development of image analysis algorithms using artificial intelligence Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of... Read more

PerkinElmer and American Society of Hematology Announce Global Collaboration to Help Combat Sickle Cell Disease

Initiative to enhance newborn screening in underserved populations for improved health outcomes in Africa WALTHAM, Mass. – June 18, 2020 – PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with the American Society of Hematology (ASH), the world’s largest professional society of hematologists, to support a... Read more

Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020

Basel, 13 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual... Read more

Takara Bio Group’s Formulation of Long-Term Management Plan FY2026 and Medium-Term Management Plan FY2023

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more